Raj Prabhakar

Biography

Since 2015, Raj Prabhakar has served as Head of Business Development, and reports directly to CEO Dr. David Mazzo. Raj leads all out-licensing, in-licensing, M&A and partnership opportunities, and serves on the Executive Committee of Caladrius Biosciences. Current priorities include global partnerships for each of the investigational clinical candidates in immune-oncology, immune-modulation and cardiovascular indications, in addition to manufacturing JVs and acquisitions. Prior to Caladrius Biosciences, Raj Prabhakar served as Vice President and Head of Business Development for Celsion Corporation from 2004 to 2015, including the acquisition of EGEN, Inc. a gene therapy and delivery company. At Celsion-EGEN, he led partnerships for immune-oncology gene therapy, small molecules, new formulations, and oligonucleotide delivery for DNA, RNA and gene editing candidates. Raj has particular transaction experience in Asia-Pacific with leading pharmaceutical companies in Japan and China. Prior to Celsion Raj was employed at PATH Global Vaccine Development Group, Protiveris, Osiris Therapeutics, and Harvard Medical School-Brigham & Women’s Hospital in multiple corporate development, business development, commercialization and research roles. Raj holds an MBA from the Harvard Business School and dual Bachelors of Science Degrees in Biology and Mechanical Engineering from the Massachusetts Institute of Technology. 

Research Interest

 Business development, commercialization and research roles.business development, commercialization and research roles.